chr7-117540119-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_000492.4(CFTR):c.889C>T(p.Arg297Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R297Q) has been classified as Likely benign.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.889C>T | p.Arg297Trp | missense_variant | 8/27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250500Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135464
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460930Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726782
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74428
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:4Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not provided, no classification provided | literature only | ClinVar Staff, National Center for Biotechnology Information (NCBI) | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 15, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2023 | The p.R297W variant (also known as c.889C>T), located in coding exon 8 of the CFTR gene, results from a C to T substitution at nucleotide position 889. The arginine at codon 297 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was described in an individual with congenital bilateral absence of the vas deferens, who reportedly had additional CFTR variants detected, including the 5T allele in trans and homozygous p.Q1352H alleles (Dörk T et al. Hum Genet, 1997 Sep;100:365-77). This variant was also detected in a pediatric chronic pancreatitis cohort in one case who was heterozygous for this variant with no additional variants reported (Sultan M et al. J Pediatr Gastroenterol Nutr, 2012 May;54:645-50). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 297 of the CFTR protein (p.Arg297Trp). This variant is present in population databases (rs397508814, gnomAD 0.03%). This missense change has been observed in individual(s) with chronic or recurrent pancreatitis and congenital absence of the vas deferens (PMID: 9272157, 22094894). ClinVar contains an entry for this variant (Variation ID: 54080). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 10, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | The CFTR c.889C>T; p.Arg297Trp variant (rs397508814) is reported in the literature in individuals with CFTR-related disorders including congenital absence of vas deferens and pancreatitis (Dork 1997, Sultan 2012, Yang 2015). This variant is also reported in ClinVar (Variation ID: 54080). It is observed in the general population with an overall allele frequency of 0.005% (12/250500 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.859). However, due to limited clinical and functional data, the significance of this variant is uncertain at this time. References: Dork T et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997 Sep;100(3-4):365-77. PMID: 9272157. Sultan M et al. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr. 2012 May;54(5):645-50. PMID: 22094894. Yang X et al. Novel mutations and polymorphisms in the CFTR gene associated with three subtypes of congenital absence of vas deferens. Fertil Steril. 2015 Nov;104(5):1268-75.e1-2. PMID: 26277102. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 25, 2023 | Variant summary: CFTR c.889C>T (p.Arg297Trp) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 250500 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing Non-Classic Cystic Fibrosis (4.8e-05 vs 0.013), allowing no conclusion about variant significance. c.889C>T has been reported in the literature as a compound heterozygous genotype with the 5T allele on the background of a homozygous c.4056G>C (p.Gln1352His) genotype in an individual affected with CBAVD (Dork_1997). This finding is interpreted as a complex allele in cis with c.4056G>C (p.Gln1352His). It has also been reported as a non-informative (second allele not specified) genotype in an individual with chronic pancreatitis (CP) (Sultan_2012). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 9272157, 19810821, 22094894, 26277102). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
CFTR-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 01, 2018 | - - |
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 03, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at